The disclosure relates to compounds of formula I, which are formyl peptide 2 (FPR2) receptor agonists. The disclosure also provides compositions and methods of using the compounds, for example, for the treatment of atherosclerosis, heart failure, chronic obstructive pulmonary disease (COPD), and related diseases.
该披露涉及到式I的化合物,这些化合物是
甲醛肽2(FPR2)受体激动剂。该披露还提供了这些化合物的组合物和使用方法,例如用于治疗动脉粥样硬化、心力衰竭、慢性阻塞性肺病(
COPD)及相关疾病。